Puma Biotechnology Inc. (PBYI)
3.35
-0.23 (-6.42%)
At close: Mar 03, 2025, 3:59 PM
3.47
3.43%
After-hours: Mar 03, 2025, 04:01 PM EST
Puma Biotechnology Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Revenue | 230.47M | 235.64M | 228M | 253.2M | 225.1M | 272.3M | 251M | 27.7M | n/a | n/a | n/a | n/a | n/a | -281.1K | n/a | n/a | n/a | n/a |
| Cost of Revenue | 64.4M | 62.68M | 55.1M | 63.7M | 39.4M | 36.8M | 34.6M | 5.6M | 1.15M | 776K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 166.06M | 172.96M | 172.9M | 189.5M | 185.7M | 235.5M | 216.4M | 22.1M | -1.15M | -776K | n/a | n/a | n/a | -281.1K | n/a | n/a | n/a | n/a |
| Operating Income | 30.97M | 32.64M | 23.7M | -8.9M | -30.4M | -39.1M | -94.7M | -292.4M | -276.6M | -240.3M | -142.3M | -54.83M | -74.4M | -10.16M | -15.98K | -16.84K | -14.08K | -15.09M |
| Interest Income | 4.72M | 2.6M | 800K | 100K | 500K | 2.8M | 1.8M | 1.2M | 1M | 1M | 300K | 172K | 100K | 3.78K | n/a | n/a | n/a | n/a |
| Pretax Income | 24.1M | 22.67M | 500K | -28.8M | -59.8M | -75.6M | -113.6M | -292M | -276M | -239.3M | -142M | -54.66M | -74.3M | -10.23M | -15.98K | -16.84K | -14.08K | -15.09M |
| Net Income | 30.28M | 21.59M | 912K | -29.1M | -60M | -82.72M | -113.6M | -292M | -276M | -239.3M | -142M | -54.66M | -74.3M | -10.23M | -15.98K | -16.84K | -14.08K | -15.09M |
| Selling & General & Admin | 80.16M | 89.31M | 90M | 116.3M | 118.4M | 141.7M | 146.2M | 106.7M | 53.8M | 31.8M | 19.4M | 9.79M | 24.8M | 9.32M | 15.98K | 16.84K | 14.08K | n/a |
| Research & Development | 54.94M | 50.38M | 52.2M | 71.9M | 97.7M | 132.9M | 164.9M | 207.8M | 222.8M | 208.5M | 122.9M | 45.05M | 49.6M | 826.37K | n/a | n/a | n/a | n/a |
| Other Expenses | n/a | 625K | -28K | 300K | 400K | 200K | -9.7M | -100K | -400K | 25K | -14K | 2K | 293K | 10.7K | n/a | n/a | n/a | -15.09M |
| Operating Expenses | 135.1M | 140.31M | 142.2M | 188.2M | 216.1M | 274.6M | 311.1M | 314.5M | 276.6M | 240.3M | 142.3M | 54.83M | 74.4M | 10.16M | 15.98K | 16.84K | 14.08K | -15.09M |
| Interest Expense | -12.45M | 13.33M | 11.5M | 12.8M | 14.1M | 15M | 11M | 700K | 958K | 971K | 324K | 172K | 98K | 3.78K | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | 881K | 22K | 6K | -88K | 1.19M | 12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 199.5M | 203M | 197.3M | 251.9M | 255.5M | 311.4M | 345.7M | 320.1M | 276.6M | 240.3M | 142.3M | 54.83M | 74.4M | 10.16M | 15.98K | 16.84K | 14.08K | -15.09M |
| Income Tax | -897K | 1.08M | 500K | 300K | 200K | 7.12M | -7.92M | -2.21M | -2.15M | -1.75M | -941K | -172K | -267K | 76.22K | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 48.65M | 47.13M | 44.67M | 40.64M | 39.58M | 38.77M | 37.94M | 37.17M | 33.3M | 32.13M | 30.01M | 28.7M | 21.73M | 20.04M | 7.75M | 3M | 3M | 39.29M |
| Shares Outstanding (Diluted) | 49.1M | 47.55M | 44.93M | 40.64M | 39.58M | 38.77M | 37.94M | 37.17M | 33.3M | 32.13M | 30.01M | 28.7M | 21.73M | 20.04M | 7.75M | 3M | 3M | 39.29M |
| EPS (Basic) | 0.62 | 0.46 | 0.02 | -0.72 | -1.52 | -2.13 | -2.99 | -7.86 | -8.29 | -7.45 | -4.73 | -1.9 | -3.42 | -0.51 | -0.00 | -0.01 | -0.00 | -0.38 |
| EPS (Diluted) | 0.62 | 0.45 | 0.02 | -0.72 | -1.52 | -2.13 | -2.99 | -7.86 | -8.29 | -7.45 | -4.73 | -1.9 | -3.42 | -0.51 | -0.00 | -0.01 | -0.00 | -0.38 |
| EBITDA | 30.97M | 47.52M | 20.97M | -5.4M | -38.54M | -55.72M | -95.21M | -288.42M | -275.45M | -239.5M | -141.65M | -54.41M | -74.09M | -10.22M | -15.98K | -16.84K | -14.08K | -15.09M |
| Depreciation & Amortization | n/a | 11.52M | 8.92M | 10.6M | 7.2M | 4.8M | 7.38M | 2.81M | 1.15M | 776K | 627K | 423K | 265K | 10.7K | n/a | n/a | n/a | n/a |